Evaluation of prognostic factors in AML. Preface. [electronic resource]
Producer: 20120409Description: 485-8 p. digitalISSN:- 1532-1924
- Aged
- Aminoglycosides -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- CCAAT-Enhancer-Binding Proteins -- genetics
- Cytarabine -- administration & dosage
- DNA (Cytosine-5-)-Methyltransferases -- genetics
- DNA Methyltransferase 3A
- Europe -- epidemiology
- Gemtuzumab
- Humans
- Leukemia, Myeloid, Acute -- diagnosis
- Middle Aged
- Mutation
- Prognosis
- Survival Analysis
- United States -- epidemiology
No physical items for this record
Publication Type: Congress; Editorial
There are no comments on this title.
Log in to your account to post a comment.